ABSTRACT
The validation of steam sterilization in autoclaves consti-
tutes perhaps the most-studied validation problem faced
by the pharmaceutical industry. Indeed, it was failure to
sterilize certain LVP solutions that resulted in several
patient deaths, prompting the U.S. FDA to call for the
“validation” of sterilization processes. Because of this,
autoclave sterilization was the first validation program
undertaken by the industry. This requirement soon
spread to other pharmaceutical processes. Sterilization
in autoclaves remains a universal issue in nearly all
facilities where sterile operations occur and continues to
be of paramount concern to both the industry and the
various international drug regulatory agencies.